Walmart, McKesson Partner for Lower-Priced Generic Drugs

Press enter to search
Close search
Open Menu

Walmart, McKesson Partner for Lower-Priced Generic Drugs

05/18/2016

The move is a win for McKesson’s generic drugs buying unit, which was hurt by the expiration of its contract with UnitedHealth Group’s Optum unit and changes in contracts with Omnicare and mass-merchant Target. Each week, roughly 140 million customers visit Walmart’s stores, and the retailer makes about $20 billion in pharmaceutical sales annually, including $4 billion from generics. Walmart has been pushing for years to reduce generic drug prices as it attempts expansion into health care, which can help bring more people into stores.

RELATED TOPICS